ebulised Budesonide as an adjunct to standard first line therapy for emergency management of moderate to severe acute asthma exacerbations in children aged 2 to 18 years age. - NI

Government Medical College and Hospital Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Children 2 to 18 years of age diagnosed to have an acute exacerbation of asthma. The diagnosis will be based on the following criteria:
•1.Children aged 2 to 18 years of age presenting to paediatric emergency with acute exacerbation of asthma having Paediatric asthma severity score of 8 to 15
•2. Is a known case of childhood asthma or past history of at least two similar episodes in last 12 months relieved with bronchodilator therapy or already on controller therapy or with family history of asthma ,atopy ,nebulisations or personal history of atopic dermatitis, food allergy or allergic rhinitis.

•1. Presence of signs or symptoms suggestive of pneumonia, tuberculosis, heart disease croup, pertussis, measles, foreign body aspiration.
•2.Documented fever >38 degrees Celsius
•3.Life threatening exacerbation attack necessitating PICU admission and/or intubation owing to respiratory failure or depressed consciousness (GCS <8), and/or inotropes
•4.Children enrolled in any other trial.
•5.Children previously enrolled in this trial within last one month
•6.Children who have received systemic corticosteroids for any indication within the previous 4weeks

发起方

Government Medical College and Hospital Chandigarh